Methods and devices for in-situ crosslinking of vascular tissue

• US 20040230156A1
• Filed: 06/27/2003
• Published: 11/18/2004
• Est. Priority Date: 02/13/2003
• Status: Abandoned Application

• Current Assignee: Erich Horst Wolf, Ross Tsukashima, Stefan Georg Schreck
• Original Assignee: Erich Horst Wolf, Ross Tsukashima, Stefan Georg Schreck
• Inventors: Schreck, Stefan Georg, Wolf, Erich Horst, Tsukashima, Ross
• Application Number:
  US10/606,952
• Publication Number:
  US 20040230156A1
• Time in Patent Office: Days
• US Class Current: 604/96.01
• CPC Class Codes: A61L 2300/422 Anti-atherosclerotic agents
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes

Abstract

A method for treating vulnerable plaque by crosslinking the fibrous cap, or collagenous extra cellular matrix layer, on the inner wall or vascular intima of the vessel. The method includes providing a vascular catheter, delivering a crosslinking agent to the extra cellular matrix layer with the vascular catheter, and irradiating the extra cellular matrix layer and crosslinking agent with light energy emitted from the vascular catheter. The crosslinking agent may be a saccharide, Riboflavin or Riboflavin-5-phosphate, or a photooxidizer. The irradiation energy is emitted from one or more LEDs mounted on the catheter. Catheter balloons are used to clear the optical path of blood so that short wavelength light can be used. The balloons may also be used to facilitate delivery of the crosslinking agent to the extra cellular matrix layer. A perfusion lumen ensures continuous blood flow during the procedure.

Claims

1. A method for crosslinking an extra cellular matrix layer in the vascular system of the body comprising:

providing a vascular catheter;

delivering a crosslinking agent to the extra cellular matrix layer with the vascular catheter; and

irradiating the extra cellular matrix layer and crosslinking agent with light energy emitted from the vascular catheter.

2. A method according to claim 1, wherein the crosslinking agent contains Riboflavin or Riboflavin-5-phosphate.

3. A method according to claim 2, wherein the wavelength of the irradiation energy is between about 200 nm and 500 nm.

4. A method according to claim 3, wherein the wavelength of the irradiation energy is between about 320 nm and 400 nm.

5. A method according to claim 1, wherein the crosslinking agent contains a saccharide or a phosphate derivative thereof.

6. A method according to claim 5, wherein the wavelength of the irradiation energy is between about 150 nm and 400 nm.

7. A method according to claim 6, wherein the crosslinking agent further contains traces of metals.

8. A method according to claim 5, wherein the crosslinking agent further contains a photosensitizer that generates oxygen radicals when irradiated.

9. A method according to claim 5, wherein the crosslinking agent further contains hydrogen peroxide.

10. A method according to claim 8, wherein the crosslinking agent further contains traces of metals.

11. A method according to claim 9, wherein the crosslinking agent further contains traces of metals.

12. A method according to claim 1, wherein the vascular catheter includes one or more light emitting diodes mounted thereon which provide the energy for the step of irradiating.

13. A method for crosslinking an extra cellular matrix layer in the vascular system of the body comprising:

delivering a saccharide to the extra cellular matrix layer; and

irradiating the extra cellular matrix layer and saccharide with light energy to crosslink the extra cellular matrix layer.

14. A method according to claim 13, wherein the wavelength of the light energy is between about 150 and 450 nm.

15. A method according to claim 14, wherein the saccharide further contains traces of metals.

16. A method according to claim 13, wherein the saccharide further contains a photosensitizer that generates oxygen radicals when irradiated.

17. A method according to claim 13, wherein the saccharide further contains traces of metals.

18. A method according to claim 13, wherein the saccharide further contains hydrogen peroxide.

19. A method according to claim 18, wherein the saccharide further contains traces of metals.

20. A method according to claim 13, wherein the saccharide is selected from the group consisting of:

glucose or a phosphate derivative thereof;

ribose or a phosphate derivative thereof; and

fructose or a phosphate derivative thereof.

21. A method according to claim 13, wherein the method includes delivering the saccharide to the extra cellular matrix layer and irradiating the extra cellular matrix layer and saccharide with light energy using a dual-purpose catheter.

22. A method for crosslinking an extra cellular matrix layer in the vascular system of the body comprising:

delivering an agent selected from the group consisting of Riboflavin and Riboflavin-5-phosphate to the extra cellular matrix layer; and

irradiating the extra cellular matrix layer and Riboflavin or Riboflavin-5-phosphate with light energy to crosslink the extra cellular matrix layer.

23. A method according to claim 22, wherein the wavelength of the light energy is between about 200 nm and 500 nm.

24. A method according to claim 23, wherein the wavelength of the light energy is about 220-225 nm, 266 nm, 371 nm, 444 nm, or 475 nm.

25. A method according to claim 22, wherein the method includes delivering the Riboflavin or Riboflavin-5-phosphate to the extra cellular matrix layer and irradiating the extra cellular matrix layer and Riboflavin or Riboflavin-5-phosphate with light energy using a dual-purpose catheter.

26. A method according to claim 22, wherein the agent further contains hydrogen peroxide.

27. A method according to claim 22, wherein the agent further contains traces of metals.

28. A method for crosslinking an extra cellular matrix layer in the vascular system of the body comprising:

delivering a photoxidizer to the extra cellular matrix layer; and

irradiating the extra cellular matrix layer and photooxidizer with light energy to crosslink the extra cellular matrix layer.

29. A vascular catheter for delivering light energy to a blood vessel wall comprising:

a light-emitting diode (LED) on the distal end of the catheter,

a transparent balloon mounted over the LED; and

a lumen opening distal and proximal to the balloon.

30. The catheter of claim 29, wherein the lumen is of sufficient size for blood perfusion therethrough.

31. The catheter of claim 29, further including a guidewire, wherein the lumen is of sufficient size to function as a lumen for passage of the guidewire.

32. The catheter of claim 29, wherein the balloon is mounted eccentrically onto the balloon to create a void between the catheter and the body vessel for perfusion of the vessel distal to the catheter.

33. The catheter of claim 29, wherein the balloon forms a cavity between the outer surface of the balloon and the vessel wall for holding a therapeutic agent.

34. The catheter of claim 33, wherein the balloon has a dog-bone shape.

35. The catheter of claim 29, further comprising:

a photo-sensitive agent contained in the balloon.

36. The catheter of claim 29, wherein there are at least two balloons mounted parallel to each other, and wherein the inflation of the balloons creates a void between the balloons, the catheter, and the vessel wall for perfusion of the vessel distal to the catheter.

37. The catheter of claim 36, wherein there are just two balloons mounted on opposite sides of the catheter and one is larger than the other and covers the LED.

38. The catheter of claim 36, wherein there are four balloons mounted along longitudinal quadrants of the catheter and connected to at least two inflation lumens.

39. The catheter of claim 36, wherein there are four arrays of axially spaced LEDs mounted along the catheter and beneath the respective balloons.

40. The catheter of claim 29, wherein the balloon is permeable.

41. The catheter of claim 29, wherein there is a permeable balloon and a non-permeable balloon, and wherein the non-permeable balloon is contained within the permeable balloon.

42. The catheter of claim 40, wherein the balloon contains a photo-sensitive agent.

43. The catheter of claim 40, wherein the balloon contains a crosslinking agent.